期刊文献+

MED19(LCMR1)基因在肿瘤中的表达及生物学功能的研究进展

Research advances in expression and biological function of MED19 in tumor
下载PDF
导出
摘要 中介体复合物(mediator complex subunit,MED)是广泛存在于酵母和哺乳动物体内的一种高度保守的多蛋白体复合物,参与转录因子与RNA聚合酶Ⅱ(RNA polymeraseⅡ,RNA pol-Ⅱ)间的信息传递过程。MED19作为人中介体复合物的亚基之一,与人生长发育,尤其是肿瘤发生发展密切相关。本文对人MED19基因的结构和生物学功能研究进展进行综述,为后续MED19研究提供依据与思路。 Mediator complex subunit(MED)is a highly conserved multiprotein complex which is widely existing in yeast and mammals,and it is involved in the information transfer process between transcription factors and RNA pol-II.As one of the subunits of human mediator complex,MED19 is closely related to human growth and development,especially to tumorigenesis and development.In this paper,the research advances in the structure and biological function of human MED19 will be reviewed to provide ideas for subsequent research on MED19.
作者 刘鹿 陈良安 LIU Lu;CHEN Liang'an(Chinese PLA Medical School,Beijing 100853,China;Department of Nutrition,the First Medical Center,Chinese PLA General Hospital,Beijing 100853,China;Department of Pulmonary and Critical Care Medicine,the Eighth Medical Center,Chinese PLA General Hospital,Beijing 100853,China)
出处 《解放军医学院学报》 CAS 北大核心 2023年第4期429-432,F0003,共5页 Academic Journal of Chinese PLA Medical School
基金 军委科学技术委员会国防科技项目(2021-JCJQ-ZD-077-12)。
关键词 中介体复合物 LCMR1 MED19 肿瘤 mediator complex LCMR1 MED19 tumor
  • 相关文献

参考文献10

二级参考文献41

  • 1周铮.DEK与肺癌发生发展机制的研究进展[J].中国实用内科杂志,2013,33(S1):159-163. 被引量:3
  • 2耿长新,曾昭冲,周长宏,王吉耀,亓玉琴.多烯紫杉醇体内对肝癌放化疗及其对p21和bcl-2表达影响[J].世界华人消化杂志,2005,13(24):2848-2852. 被引量:9
  • 3Shaobin Wu,Xianwei Wang,Jinxiang Chen,Yuxiang Chen.Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells[J]. Biochemical and Biophysical Research Communications . 2013 (4)
  • 4Barboule N,Chadebech P,Baldin V,et al.Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line. Oncegene . 1997
  • 5Hata Taishi,Yamamoto Hirofumi,Ngan Chew Yee,Koi Minoru,Takagi Akimitsu,Damdinsuren Bazarragchaa,Yasui Masayoshi,Fujie Yujiro,Matsuzaki Takeshi,Hemmi Hiromichi,Xu Xundi,Kitani Kotaro,Seki Yosuke,Takemasa Ichiro,Ikeda Masataka,Sekimoto Mitsug.Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. Molecular Cancer . 2005
  • 6Giannakakou P,Poy G,Zhan Z,Knutsen T,Blagosklonny M V,Fojo T.Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. Oncegene . 2000
  • 7Kelling Jonathan,Sullivan Kevin,Wilson Leslie,Jordan Mary Ann.Suppression of centromere dynamics by Taxol in living osteosarcoma cells. Cancer Research . 2003
  • 8Gang Li,Jingfeng Zhao,Xianjing Peng.Radiation/Paclitaxel Treatment of p53-Abnormal Non-Small Cell Lung Cancer Xenograft Tumor and Associated Mechanism. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS . 2012
  • 9Li-Hua Li,Jie He,Dong Hua.Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro. CANCER CHEMOTHERAPY AND PHARMACOLOGY . 2011
  • 10Pharoah PD,Day NE,Caldas C.Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. British Journal of Cancer . 1999

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部